Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q2 2025 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2025-07-08

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Jul 8, 2025

Total Value: $427M (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 61.4%

Value $262M Shares 19,963,157 Share Price $13.14 Est. Cost/Share $20.88 Unrealized @ Report Date —

PHAT PHATHOM PHARMACEUTICALS INC 16.8%

Value $71.59M Shares 7,464,572 Share Price $9.59 Est. Cost/Share $13.72 Unrealized @ Report Date -30.1%

NAMS NEWAMSTERDAM PHARMA COMPANY 12.2%

Value $51.97M Shares 2,869,565 Share Price $18.11 Est. Cost/Share $10.96 Unrealized @ Report Date +65.3%

RAPT RAPT THERAPEUTICS INC 5.2%

Value $22.35M Shares 2,794,000 Share Price $8.00 * Est. Cost/Share $7.63 Unrealized @ Report Date 0.0%

AURA AURA BIOSCIENCES INC 4.5%

Value $19.03M Shares 3,039,892 Share Price $6.26 Est. Cost/Share $17.87 Unrealized @ Report Date -65.0%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$262M	61.4%	$13.14	$20.88	—	SPONSORED ADS	152309100
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$71.59M	16.8%	$9.59	$13.72	-30.1%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$51.97M	12.2%	$18.11	$10.96	+65.3%	ORDINARY SHARES	N62509109
RAPT	RAPT THERAPEUTICS INC	2,794,000	$22.35M	5.2%	$8.00 *	$7.63	0.0%	COM	75382E208
AURA	AURA BIOSCIENCES INC	3,039,892	$19.03M	4.5%	$6.26	$17.87	-65.0%	COM	05153U107